JSP 545 (Digoxin 250 mcg (0.25 mg))

Pill imprint JSP 545 has been identified as Digoxin 250 mcg (0.25 mg).

Digoxin is used in the treatment of atrial fibrillation; heart failure and belongs to the drug classes group V antiarrhythmics, inotropic agents. Risk cannot be ruled out during pregnancy. Digoxin 250 mcg (0.25 mg) is not subject to the Controlled Substances Act.

See also related documents.

Images for JSP 545 (Digoxin 250 mcg (0.25 mg))

Digoxin 250 mcg (0.25 mg) JSP 545
Digoxin 250 mcg (0.25 mg) JSP 545  Front
Digoxin 250 mcg (0.25 mg) JSP 545  Back
Digoxin 250 mcg (0.25 mg) JSP 545
Digoxin
Imprint:
JSP 545
Strength:
250 mcg (0.25 mg)
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Group V antiarrhythmics
Inotropic agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Lannett Company, Inc.
National Drug Code (NDC):
00527-1325
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
lactose anhydrous
magnesium stearate
microcrystalline cellulose
stearic acid
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
62584-0990 Amerisource Health Services
66336-0607 Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Questions about Atrial Fibrillation? Get answers from our expert. Watch Video

Close
Hide
(web5)